U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV
Go back to U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV| Pfizer Inc. (NYSE: PFE) | Delayed: 26.62 -0.43 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.05 | 52 Week High | $37.39 | |||
| Open | $26.94 | 52 Week Low | $28.25 | |||
| Day High | $27.20 | P/E | 16.13 | |||
| Day Low | $26.47 | EPS | $1.65 | |||
| Volume | 37,941,334 | |||||
